Trial intelligence / Profile preview

Effect of Atropine vs Tropicamide on Ciliary Muscle Morphology

NCT05449015Phase 4Unknown

Start
Dec 2020
Primary completion
Mar 2023
Modality
Classical Binding Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of atropine in myopia (2 arms). Primary endpoints: ciliary thickness parameters and the distance between ciliary muscle apex and scleral spur. Status: unknown.

02

Drugs

atropine
03

Conditions

myopia

Beyond the preview

Go deeper on NCT05449015.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05449015.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call